Literature DB >> 15107171

Pathways to treatment for tuberculosis in Bali: patient perspectives.

Rochelle E Watkins1, Aileen J Plant.   

Abstract

The authors explored treatment-seeking behavior among people with tuberculosis (TB) in Bali, Indonesia. They conducted in-depth interviews with 5 people who had been diagnosed with TB and 6 people who were suspected of having TB but who had not yet received a diagnosis. Participants reported frequent delays in obtaining a diagnosis of TB and obtaining adequate treatment. The authors describe issues associated with treatment-seeking behavior using the following five main themes: awareness of TB-causes, symptoms, and seriousness; influence of others; treatment quality; treatment barriers and default; and stigma and fear. Their findings reinforce the importance of a comprehensive TB control program that provides quality diagnostic and treatment services, and patient and community education, and enables patient involvement in treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15107171     DOI: 10.1177/1049732304263628

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  22 in total

Review 1.  Tuberculosis and stigmatization: pathways and interventions.

Authors:  Andrew Courtwright; Abigail Norris Turner
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

2.  Qualitative interviews with non-national tuberculosis patients in Cairo, Egypt: understanding the financial and social cost of treatment adherence.

Authors:  Anna L Lohiniva; Alaa Mokhtar; Ashraf Azer; Esaam Elmoghazy; Eman Kamal; Manal Benkirane; Erica Dueger
Journal:  Health Soc Care Community       Date:  2015-10-01

3.  Coping with future epidemics: Tai chi practice as an overcoming strategy used by survivors of severe acute respiratory syndrome (SARS) in post-SARS Hong Kong.

Authors:  Judy Yuen-Man Siu
Journal:  Health Expect       Date:  2014-09-15       Impact factor: 3.377

Review 4.  Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Authors:  Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink
Journal:  PLoS Med       Date:  2007-07-24       Impact factor: 11.069

5.  Influence of social experiences in shaping perceptions of the Ebola virus among African residents of Hong Kong during the 2014 outbreak: a qualitative study.

Authors:  Judy Yuen-man Siu
Journal:  Int J Equity Health       Date:  2015-10-05

6.  Barriers to Point-of-Care Testing in India: Results from Qualitative Research across Different Settings, Users and Major Diseases.

Authors:  Nora Engel; Gayatri Ganesh; Mamata Patil; Vijayashree Yellappa; Nitika Pant Pai; Caroline Vadnais; Madhukar Pai
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

7.  Patients' Experience of Tuberculosis Treatment Using Directly Observed Treatment, Short-Course (DOTS): A Qualitative Study.

Authors:  Masoud Behzadifar; Masoud Mirzaei; Meysam Behzadifar; Abouzar Keshavarzi; Maryam Behzadifar; Maryam Saran
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

8.  Public and/or private health care: tuberculosis patients' perspectives in Myanmar.

Authors:  Saw Saw; Lenore Manderson; Mridula Bandyopadhyay; Than Tun Sein; Myo Myo Mon; Win Maung
Journal:  Health Res Policy Syst       Date:  2009-07-28

9.  Journeys to tuberculosis treatment: a qualitative study of patients, families and communities in Jogjakarta, Indonesia.

Authors:  N Rintiswati; Y Mahendradhata; Y Subronto; C M Varkevisser; M J van der Werf
Journal:  BMC Public Health       Date:  2009-05-27       Impact factor: 3.295

10.  Delayed diagnosis and associated factors among new pulmonary tuberculosis patients diagnosed at the emergency department of a tertiary care hospital in Porto Alegre, South Brazil: a prospective patient recruitment study.

Authors:  Gracieli Nadalon Deponti; Denise Rossato Silva; Ana Cláudia Coelho; Alice Mânica Muller; Paulo de Tarso Roth Dalcin
Journal:  BMC Infect Dis       Date:  2013-11-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.